Efficacy of three ACTs in treating falciparum malaria in the Democratic Republic of Congo
This clinical study aims to assess the efficacy of amodiaquine-artesunate for the treatment of uncomplicated P. falciparum malaria in children in Kinshasa, DRC, five years after its introduction as a first line treatment. It also compares this therapy with the efficacies of dihydroartemisinin-piperaquine and artemether-lumefantrine. Parasite DNA from samples collected from infected patients will be genotyped to perform and association studies with observed clinical phenotypes.
Summary
- 175 Samples
- 1 Location
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Locations
Kinshasa
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers